Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pediatr Gastroenterol Nutr ; 61(4): 437-9, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25885882

RESUMO

OBJECTIVES: Lansoprazole is a proton pump inhibitor commonly used in children <12 months of age despite a lack of efficacy and safety data in this age group. To achieve lower doses in this population, many divide standard oral disintegrating tablets. This study seeks to determine if the medication is equally distributed within the tablet to allow for accurate dosing. METHODS: Ten 15-mg Prevacid SoluTabs were divided. Each portion was dissolved separately (half A, B, and the residual "dust" C) and photographed. A magnified view of the image allowed for counting each microgranule. RESULTS: The mean number and standard deviation of microgranules in half A, B, and part C were 2514.7 ±â€Š130.5, 2342.9 ±â€Š130.1, and 49.4 ±â€Š38.8, respectively. The total number of microgranules per tablet was 4907 ±â€Š140.5. There was a statistically significant difference in the mean number of microgranules in half A versus B (P = 0.0086). CONCLUSIONS: There are statistically significant differences in the amount of lansoprazole-containing microgranules within each half of a divided tablet. Clinicians must determine whether this difference is clinically relevant when prescribing "divided" medication to children.


Assuntos
Antiulcerosos/química , Lansoprazol/química , Inibidores da Bomba de Prótons/química , Antiulcerosos/administração & dosagem , Antiulcerosos/análise , Criança , Composição de Medicamentos , Liberação Controlada de Fármacos , Humanos , Lansoprazol/administração & dosagem , Lansoprazol/análise , Pediatria/métodos , Inibidores da Bomba de Prótons/administração & dosagem , Inibidores da Bomba de Prótons/análise , Reprodutibilidade dos Testes , Comprimidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...